EMERALD ADVISERS, LLC - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 42 filers reported holding OYSTER PT PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q4 2020$5,494,000
-25.6%
291,936
-16.6%
0.18%
-40.1%
Q3 2020$7,387,000
-10.1%
349,916
+23.0%
0.30%
-15.1%
Q2 2020$8,216,000
+3.5%
284,485
+25.4%
0.36%
-22.0%
Q1 2020$7,941,000
-13.1%
226,881
-39.3%
0.46%
+18.9%
Q4 2019$9,141,000374,0040.39%
Other shareholders
OYSTER PT PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$32,226,00014.34%
Paradigm Biocapital Advisors LP 987,698$11,497,0003.04%
NEA Management Company, LLC 5,925,287$68,970,0001.99%
KPCB XIV Associates, LLC 367,987$4,283,0001.61%
Telemark Asset Management, LLC 787,026$9,161,0000.81%
COWEN AND COMPANY, LLC 509,794$5,934,0000.57%
RTW INVESTMENTS, LP 2,058,504$23,961,0000.50%
ACT CAPITAL MANAGEMENT, LLC 13,500$157,0000.17%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$12,101,0000.11%
Wildcat Capital Management, LLC 36,847$429,0000.11%
View complete list of OYSTER PT PHARMA INC shareholders